Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Trial testing increasing doses of zongertinib tablet in advanced cancer with HER2 gene changes, then evaluating tumour response at tolerated dose.